MedTrace Logo

All Polyethylene Tibia-VEGA Kiel

NCT02756702 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2023-06-26

No results posted yet for this study

Summary

Obligatory Post-Marketing Clinical Follow-up (PMCF) as part of the post marketing surveillance plan for the product under investigation For this PMCF only CE-marked medical devices will be used within their intended purpose and no additional invasive or other stressful examinations are to be carried out (acc. to MPG §23b).

Conditions

  • Degenerative Osteoarthritis
  • Rheumatoid Arthritis
  • Post-traumatic; Arthrosis
  • Other Instability, Knee
  • Stiffness of Knee, Not Elsewhere Classified
  • Deformity of Knee Joint

Interventions

DEVICE

All-Poly

Implantation of the VEGA PS using all-polyethylene tibia components

Sponsors & Collaborators

  • Frictionless GmbH, Kiel

    collaborator UNKNOWN

  • Aesculap AG

    lead INDUSTRY

Principal Investigators

  • Ludger Gerdesmeyer, Professor · orthopedics

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-12-31
Completion
2022-10-06

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02756702 on ClinicalTrials.gov